A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection. Mayer KA, Schrezenmeier E, Diebold M, Halloran PF, et al. N Engl J Med 2024;391:122-132.

Read + Share

Amedeo Smart

Independent Medical Education

Mayer KA, Schrezenmeier E, Diebold M, Halloran PF, et al. A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection. N Engl J Med 2024;391:122-132.
PMID: 38804514